Ipsen
Clinical trials sponsored by Ipsen, explained in plain language.
-
New study tracks Long-Term safety of itching drug for rare liver disease
Disease control Not yet recruitingThis study will follow 30 patients with Alagille syndrome who are taking odevixibat, a medication that helps control severe itching caused by liver problems. The goal is to monitor the drug's long-term safety in everyday use. Participants must be 6 months or older and already tak…
Sponsor: Ipsen • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New study tracks pregnancy safety for elafibranor users
Knowledge-focused Not yet recruitingThis study watches over people who took elafibranor shortly before or during pregnancy. It aims to see if the drug affects the baby's health or causes birth defects. No extra tests or treatments are given—only routine medical records are reviewed. The study will last about 10 yea…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC